 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Axon Enterprise Inc (AXON) was identified as having a larger market cap than the smaller end of the S&P 500, for example Federal Realty Investment Trust (FRT), according to The Online Investor. Click ...

Axon Enterprise Larger Than S&amp;P 500 Component Federal Realty Investment Trust

Axon to Release Second Quarter 2022 Earnings on August 9, 2022 Axon to Release Second Quarter 2022 Earnings on August 9, 2022 PR Newswire SCOTTSDALE, Ariz., July 27, 2022 SCOTTSDALE, Ariz., July 27, 2022 /PRNewswire/ -- Axon (Nasdaq: AXON), the global leader in connected public safety technologies...

Axon to Release Second Quarter 2022 Earnings on August 9, 2022

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the ProShares ...

Analysts See 18% Upside For UXI

Several Major Cities Across Canada to Deploy Axon's TASER 7 Device Several Major Cities Across Canada to Deploy Axon's TASER 7 Device PR Newswire CALGARY, ON and SCOTTSDALE, Ariz., July 18, 2022 To date, over 50 agencies in Canada are now using TASER 7, keeping both officers and communities safe...

Several Major Cities Across Canada to Deploy Axon's TASER 7 Device

Several Major Cities Across Canada to Deploy Axon's TASER 7 Device Several Major Cities Across Canada to Deploy Axon's TASER 7 Device Canada NewsWire CALGARY, ON and SCOTTSDALE, Ariz., July 18, 2022 To date, over 50 agencies in Canada are now using TASER 7, keeping both officers and communities...

Axon Appoints Isaiah Fields as Chief Legal Officer Axon Appoints Isaiah Fields as Chief Legal Officer PR Newswire SCOTTSDALE, Ariz., July 13, 2022 SCOTTSDALE, Ariz., July 13, 2022 /PRNewswire/ -- Axon(NASDAQ: AXON), the global leader in connected public safety technologies, today announced the...

Axon Appoints Isaiah Fields as Chief Legal Officer

These businesses take a page out of Apple's playbook.Apple has the kind of brand authority most companies will never achieve, and it has used that competitive advantage to build a very sticky business. Specifically, by pairing first-party hardware with software and services, Apple benefits from ...

Missed Out on Apple Stock? 2 Growth Stocks to Buy and Hold Forever.

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the SPDR S&...

How The Parts Add Up: MDYG Targets $86

Axon Appoints Josh Isner as Chief Operating Officer Axon Appoints Josh Isner as Chief Operating Officer PR Newswire SCOTTSDALE, Ariz., June 9, 2022 Seasoned executive to help drive Axon's next phase of growth SCOTTSDALE, Ariz., June 9, 2022 /PRNewswire/ --Axon (NASDAQ: AXON), the global leader in...

Axon Appoints Josh Isner as Chief Operating Officer

Axon Announces TASER Drone Development to Address Mass Shootings Axon Announces TASER Drone Development to Address Mass Shootings PR Newswire SCOTTSDALE, Ariz., June 2, 2022 Remotely operated, non-lethal drones key in long-term plan to detect and stop mass shootings in less than 60 seconds...

Axon Announces TASER Drone Development to Address Mass Shootings

Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. Its product pipeline focuses on Parkinson's Disease, GM1 gangliosidosis, and GM2 gangliosidosis, such as Tay-Sachs disease and Sandhoff disease. The company was founded on October 31, 2014 and is headquartered in New York, NY.

Watchers	6,728
52-Wk Low	$0.25
52-Wk High	$0.465

Market Cap	$28.7M
Volume (M)	18,716.00
52-Wk High	$0.465
52-Wk Low	$0.25

Current Price	$0.4012
Prev Close	$0.4011
Open	$0.4011
Dividend Yield	N/A
50-Day Moving Average	$0.3852
Beta	0.81
Avg. Volume	34,020.48
PE Ratio	-0.99

52-Week High	$0.465
52-Week Low	$0.25
Market Capitalization	$28.7M
EPS	-$0.3907
Price to Book	0.64
Revenue Per Employee	N/A
Enterprise Value/EBITDA	0.53

AXGT Axovant Sciences

About

Feed

News

Fundamentals